Clinical Trials Directory

Trials / Completed

CompletedNCT04733235

the Effect of Endometrial Compaction Caused by Progesterone Effect on Pregnancy Outcomes

The Effect of Progesterone Induced Endometrial Compaction on Pregnancy Outcomes in Frozen-thawed Embryo Transfer at the Blastocyst Stage

Status
Completed
Phase
Study type
Observational
Enrollment
205 (actual)
Sponsor
Akdeniz University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The purpose of this prospective cohort study is to assess the effect of endometrial compaction caused by progesterone effect on pregnancy outcomes

Detailed description

For a pregnancy to occur, the embryo must implant in a receptive endometrium during the window of implantation, which is thought to occur from day 22 to 24 of an idealized 28-day cycle. Early studies have suggested that assessing endometrial thickness with the use of ultrasound may be an alternative to invasive techniques such as endometrial biopsy for attempting to determine a receptive endometrium for frozen-thawed embryo transfer (FET). A preovulatory endometrial thickness of 7 mm or more is considered to be the cutoff for endometrial receptivity, below which many physicians would cancel an embryo transfer. However, in most studies in the literature, endometrial thickness was measured either on the day of hCG in fresh embryo transfer cases or on the last day of estrogen treatment in thawed embryo transfers. There are a limited number of studies evaluating the luteal period, embryo transfer day and endometrial thickness. Accordingly, in this prospective cohort study is to assess the effect of endometrial compaction caused by progesterone effect on pregnancy outcomes

Conditions

Interventions

TypeNameDescription
DRUGProgesteroneultrasound measurements of endometrial thickness at the end of the estrogen phase and the day of embryo transfer.

Timeline

Start date
2020-07-01
Primary completion
2021-04-15
Completion
2021-07-15
First posted
2021-02-02
Last updated
2023-01-03

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04733235. Inclusion in this directory is not an endorsement.